Antares Pharma, Inc. Made Headway
Thu, Apr 14, 2022 at 05:30 PM
Antares Pharma, Inc. (ATRS:NASDAQ) shot up at $5.56, a gain of 48.7%. On Wed, Apr 13, 2022, ATRS:NASDAQ hit a New 2-Week High of $5.58. The stock got featured on our News Catalysts scanner on Thu, Apr 14, 2022 at 01:16 PM in the 'ACQUISITION' category. From Wed, Mar 30, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days
About Antares Pharma, Inc. (ATRS:NASDAQ)
Antares Pharma Inc is a specialty pharmaceutical company. It is engaged in developing and commercializing self-administered parenteral pharmaceutical products and technologies including novel, pressure-assisted injectors.
Top 10 Gainers:
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 69.23%
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 68.6%
- Veru Inc. (VERU:NASDAQ), 49.35%
- Antares Pharma, Inc. (ATRS:NASDAQ), 48.66%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 46.24%
- Houston American Energy Corp. (HUSA:NYSEMKT), 42.94%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 40.63%
- HighPeak Energy Inc. (HPK:NASDAQ), 39.76%
- Creatd Inc. (CRTD:NASDAQ), 39.43%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 38.54%